RAP 0.00% 20.5¢ raptor resources limited

Ann: Positive Results from At-Home Sleep Apnoea Study, page-60

  1. 2,524 Posts.
    lightbulb Created with Sketch. 272
    Hello runaway,
    The OSA side of our business should, IMO, be licenced to doctors specialising in sleep/respiratory or to those companies which market the CPAP units. They have "instant recognition" branding in the marketplace and therefore no real marketing required. Or licence to both. We could also entertain the possibility/feasibility of setting up all telehealth operators with access to the app via a licence deal, to enable them to conduct the sleep tests on their patients directly...at home. However, the number one target is the cpap provider. They will be the one who really wants our app. That will then either be "shelved like the Sarrich engine" or let loose to benefit billions. Any way it goes, we win...!
    IMO
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.